Skip to main content

Magnus Blixt leaves his position as CFO of CellaVision AB

CellaVision’s Chief Financial Officer (CFO), Magnus Blixt has informed that he will leave his position as CFO of CellaVision, to take on the position as CEO of the medical technology company Dignitana AB. Magnus will continue to support CellaVision until mid-April 2022.

“Magnus has been CFO of CellaVision for more than 8 years, including a short period as acting CEO in 2020-2021. During his time in the company, Magnus has been a vital part of CellaVision’s development and success. He will be leaving CellaVision well positioned for continued growth with robust financial fundamentals in place. I would like to thank Magnus for his contributions over the years and I wish him every success with his new opportunity”, says Simon Østergaard, President and CEO of CellaVision.

“My time with CellaVision has been fantastic. I am very pleased to see that the passion and entrepreneurial spirit that I encountered in 2013 remains within the organization today. It has been incredibly inspiring to see the development of this efficient and scalable business model which has delivered profitable growth over the years. With a widened product portfolio and market presence, the journey will undoubtably continue in the future,“ says Magnus Blixt, CFO of CellaVision.

The search for a new CFO of CellaVision will be initiated immediately and the successor will be announced in due course.